Trade Ardelyx, Inc. - ARDX CFD
What is Ardelyx, Inc. (ARDX)?
Ardelyx, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for cardiorenal and gastrointestinal diseases. The company employs a proprietary drug discovery platform to identify novel therapeutic candidates aimed at addressing unmet medical needs. Ardelyx's pipeline includes product candidates targeting conditions such as chronic kidney disease and heart failure. It collaborates with pharmaceutical partners to advance clinical development and regulatory approval processes. The company operates research and development facilities dedicated to advancing its therapeutic programs. Ardelyx, Inc. operates within the biotechnology sector, which is characterized by extensive research, regulatory oversight, and clinical testing. Its strategic approach involves leveraging scientific innovation to develop treatments that improve patient outcomes. The company maintains a focus on advancing its product candidates through clinical trials and regulatory pathways.
Ardelyx, Inc. Stock Price Today: Live Overview
The price today is shaped by ongoing trading conditions, with Ardelyx, Inc. positioned at $6.1555. The session has seen values between $6.0145 and $6.2045, with a daily percentage change of +1.6738%.
FAQ: Ardelyx, Inc. (ARDX)
What is the current price of ARDX stock?
Ardelyx, Inc.'s current price is $6.1555.
Does ARDX pay dividends?
Ardelyx, Inc. does not pay dividends.
Does ARDX have a formal corporate presence or regional headquarters in the UAE?
Ardelyx, Inc. operates in the UAE only through partners and distributors without an official office or subsidiary.
What is ARDX best known for?
Ardelyx, Inc. is most famous for its development of treatments for kidney and cardiovascular diseases.
What assets are typically shown together with ARDX?
Commonly shown alongside ARDX: Invesco QQQ Trust, Live Oak Bancshares Inc, Owens Corning
Latest shares articles



